Trials / Conditions / Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
Vaginal Squamous Cell Carcinoma, Not Otherwise Specified
4 registered clinical trials studyying Vaginal Squamous Cell Carcinoma, Not Otherwise Specified.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Me NCT03452332 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) Duri NCT02466971 | National Cancer Institute (NCI) | Phase 3 |